Market Watch: Key Shares to Track Today — BEL, Vodafone Idea, KEC International, and Others

BEL, Power Grid, Jupiter Wagons

The stock market today will pay attention to BEL, Power Grid, and Jupiter Wagons today because they will announce their fourth-quarter earnings.

Vodafone Idea

Supreme Court appeal by the financially distressed telecom company Vodafone Idea about government rejection of their request to waive over $5 billion in statutory interest and penalties will likely attract attention to its buzzing stocks.

KEC International

The RPG Group company secured new transmission and distribution project contracts worth ₹1,133 crore throughout trending stocks today.

Divi's Lab

Divi’s Laboratories achieved a fourth quarter net profit of ₹662 crore while its revenue reached ₹2,585 crore during the same timeframe.

Arvind Fashions

Arvind Fashions experienced a net loss of ₹93.15 crore during the fourth quarter which represents a shift from last year's quarter profit despite their Nifty 50 increasing by 8.8% and their EBITDA rising by 18%.

Delhivery

Delhivery demonstrated its recovery during Q4 by achieving a net profit of ₹72.6 crore after reporting a loss during the same period last year. Year-over-year revenue growth reached 5.6% while EBITDA more than tripled to ₹119 crore.

Stocks to buy today

Bajaj Auto

Bajaj Auto International Holdings BV secured loan agreements worth 566 million euros with JP Morgan, DBS Bank, and Citigroup Global Markets Asia. These loans operate without collateral and must be repaid within one year.

Max Healthcare Institute

Crosslay Remedies, a subsidiary of the company, signed a sale deed to purchase a 4,000 square meter property with an existing building next to Max Super Speciality Hospital in Vaishali for ₹120 crore. The planned acquisition will allow the hospital to increase its capacity by 140 beds during the upcoming 30 months.

JSW Steel

The Board of Directors will convene on May 23 to deliberate on long-term funding options in share market today and review the dividend distribution plan.

Sun Pharma

Sun Pharma received US FDA approval for its advanced BLU-U blue light photodynamic therapy treatment for actinic keratosis.